Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 19, 2026.

A compendium of genetic regulatory effects across pig tissues

Jinyan Teng, Yahui Gao, Hongwei Yin and 97 more (opens in a new tab)

Nature Genetics · 2024 · CC BY

doi:10.21203/rs.3.rs-2261680/v1 (opens in a new tab)

Abstract

The Farm Animal Genotype-Tissue Expression (FarmGTEx) project has been established to develop a public resource of genetic regulatory variants in livestock, which is essential for linking genetic polymorphisms to variation in phenotypes, helping fundamental biological discovery and exploitation in animal breeding and human biomedicine. Here we show results from the pilot phase of PigGTEx by processing 5,457 RNA-sequencing and 1,602 whole-genome sequencing samples passing quality control from pigs. We build a pig genotype imputation panel and associate millions of genetic variants with five types of transcriptomic phenotypes in 34 tissues. We evaluate tissue specificity of regulatory effects and elucidate molecular mechanisms of their action using multi-omics data. Leveraging this resource, we decipher regulatory mechanisms underlying 207 pig complex phenotypes and demonstrate the similarity of pigs to humans in gene expression and the genetic regulation behind complex phenotypes, supporting the importance of pigs as a human biomedical model.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.

Main

Genome-wide association studies (GWAS) reveal genomic variants associated with complex phenotypes at an unprecedented speed and scale in both plants and animals, but particularly in humans,. However, most of the variants fall in noncoding regions, putatively contributing to phenotypic variation by regulating gene activity at different biological levels,. The systematic characterization of genetic regulatory effects on transcriptome (for example, expression quantitative trait loci (eQTLs)) across tissues, as carried out in the Genotype-Tissue Expression (GTEx) project in humans, has proven to be a powerful strategy for connecting GWAS loci to gene regulatory mechanisms at large scale,,.

To sustain food and agriculture production while minimizing associated negative environmental impacts, it is crucial to identify molecular mechanisms that underpin complex traits of economic importance to enable biology-driven selective breeding in farm animals. However, the annotation of regulatory variants in farm animals has so far been limited by small sample size, few tissue/cell type assayed, and in restricted genetic background–. We thus launched the international Farm Animal GTEx (FarmGTEx) project to build a comprehensive atlas of regulatory variants in domestic animal species. This resource along with the functional annotation of animal genomes project will not only facilitate fundamental biology discovery but also enhance the genetic improvement of farm animals.

Pigs are an important agricultural species by supplying meat for humans, and serve as an important biomedical model for studying human development, disease and organ xenotransplantation, due to their similarity to humans in multiple attributes such as anatomical structure, physiology and immunology. Here we report the results of the pilot PigGTEx, which is underpinned by 5,457 RNA-seq data and 1,602 whole-genome sequence (WGS) samples (Supplementary Tables 1 and 2). We test the association of transcriptomic phenotypes with 3,087,268 DNA variants in 34 pig tissues and then evaluate tissue-sharing patterns of regulatory effects. We examine multi-omics data to identify putative molecular mechanisms underlying regulatory variants and then apply this resource to dissect GWAS associations for 268 complex traits. Finally, we leverage the human GTEx resource and GWAS of 136 human complex phenotypes to assess the similarity between pigs and humans in genetic regulation of gene expression and complex phenotypes. We make the PigGTEx resources freely accessible via http://piggtex.farmgtex.org.

Data summary

After filtering out the low-quality samples from the initial set of 9,530, we retained 7,095 RNA-seq profiles for downstream analysis (Supplementary Fig. 1 and Supplementary Note). We quantified expression levels for protein-coding genes (PCG), lncRNA, exons and enhancers, and alternative splicing events in these samples. Sample clustering based on the five transcriptomic phenotypes recapitulated tissue types well (Fig. 1a,b and Supplementary Fig. 2). We called a median number of 74,347 single-nucleotide polymorphisms (SNPs) from these RNA-seq samples (Extended Data Fig. 1a,b). Leveraging a multibreed pig genomics reference panel (PGRP) consisting of 1,602 WGS samples (Supplementary Fig. 3), we imputed genotypes of RNA-seq samples with an imputation accuracy of 0.94 (concordance rate) and 0.82 (genotype correlation, r2; Extended Data Fig. 1c–n and Supplementary Table 3). The population structure of the RNA-seq samples was similar to the PGRP (Fig. 1c). After removing duplicated RNA-seq samples, we retained 5,457 samples representing 34 tissues, cell types or organ systems (all referred to as ‘tissues’ hereafter), with at least 40 samples per tissue, for subsequent analysis (Fig. 1d–e, Extended Data Fig. 2a–e and Supplementary Table 4). We further analyzed 270 multi-omics datasets in pigs, including 245 whole-genome bisulfite sequencing (WGBS; Supplementary Figs. 4 and 5 and Supplementary Tables 5–7), 20 single-cell RNA-seq (Supplementary Fig. 6 and Supplementary Table 8) and five Hi-C samples (Supplementary Tables 9 and 10).

The gene expression atlas empowers functional annotation

Gene expression was either tissue-specific or ubiquitous (Supplementary Fig. 7a and Extended Data Fig. 3a). We detected between 145 (morula) and 5,180 (frontal cortex) tissue-specific genes across 34 tissues (Extended Data Fig. 3b and Supplementary Fig. 7b). Tissue-specific genes showed a higher enrichment of active regulatory elements and a higher depletion of repressed polycomb regions in matching tissues than in nonmatching tissues (Extended Data Fig. 3c–e and Supplementary Fig. 7c,d). In addition, tissue-specific genes exhibited distinct patterns of evolutionary DNA sequence constraints across tissues (Supplementary Fig. 7e), in agreement with the hypothesis of tissue-driven evolution. To assign function to pig genes, we performed a gene co-expression analysis in each of the 34 tissues (Supplementary Fig. 8a–c). In total, we detected 5,309 co-expression modules across tissues and assigned 25,023 genes to at least one module (Supplementary Fig. 8d–f and Supplementary Table 11). Among them, 13,266 (42.57%) genes had no functional annotation in the Gene Ontology (GO) database (Extended Data Fig. 3f and Supplementary Fig. 8d); these are referred to as ‘unannotated genes’ hereafter. For instance, 42 unannotated genes were co-expressed with 59 functional annotated genes in the pituitary, which were substantially enriched in neuron apoptotic processes (Extended Data Fig. 3g). Unannotated genes were less expressed, showed weaker DNA sequence conservation, lower proportion of orthologous genes and higher tissue specificity than genes with functional annotations (Extended Data Fig. 3f). The proportion of expressed unannotated genes varied across tissues, indicating differences in functional annotation between tissues (Extended Data Fig. 3h).

MolQTL mapping

In total, 93% of tested genes had significant cis-heritability (cis-h2; within ±1 Mb of transcription start sites (TSS)) estimates in at least one tissue while accounting for hidden factors (Extended Data Fig. 2f–h and Extended Data Fig. 4a,b). We mapped molecular quantitative trait loci (molQTLs) for five molecular phenotypes, including cis-eQTL for PCG expression, cis-eeQTL for exon expression, cis-lncQTL for lncRNA expression, cis-enQTL for enhancer expression and cis-sQTL for alternative splicing. In total, 86%, 67%, 46%, 27% and 64% of all tested PCGs (n = 17,431), lncRNAs (n = 7,374), exons (n = 82,678), enhancers (n = 3,353) and genes with alternative splicing events (n = 18,331) had at least one significant variant (eVariant) detected in at least one tissue; hence, they were defined as eGenes, eLncRNAs, eExons, eEnhancers and sGenes, respectively (Supplementary Fig. 9 and Supplementary Table 12). The proportion of eGenes detected was positively correlated with sample size across tissues, similar to the other four molecular phenotypes (Fig. 2a, Extended Data Fig. 4c and Supplementary Fig. 10). The top cis-e/sQTL centered around TSS of genes (Supplementary Fig. 11a–e). Tissues with a larger sample size yielded a larger proportion of cis-eQTL with smaller effects (Supplementary Fig. 11f–g). PCG had the highest proportion of detected eGenes across tissues, followed by lncRNA, enhancer, splicing and finally exon (Fig. 2b). Notably, molecular phenotypes exhibited a high proportion (an average of 70%) of their own specific molQTL after taking linkage disequilibrium (LD) between SNPs into account (Fig. 2b), indicative of their distinct underlying genetic regulation. On average, 20% of eGenes, 13.5% of sGenes, 21.2% of eExons, 23.5% of eLncRNAs and 21% of eEnhancers had more than one independent eVariant across tissues, and the proportion increased with an increasing sample size of tissues (Fig. 2c and Extended Data Fig. 5a). Down-sampling analysis in three major tissues further confirmed an impact of sample size on the statistical power for cis-eQTL discovery (Fig. 2d). Approximately half of the independent cis-eQTL were located within ±182 kb of TSS, and those with larger effect size were closer to TSS (Extended Data Fig. 5b–d). The eGenes with more independent cis-eQTL have a higher cis-h2, but no significant differences for the median gene expression level (Fig. 2e).

We applied four distinct strategies to validate the cis-eQTL. First, the summary statistics of cis-eQTL derived from the linear regression model had a strong correlation with those from a linear mixed model (Extended Data Fig. 6a–e). Second, the internal validation yielded a high replication rate (measured by π1) of cis-eQTL, with an average π1 value of 0.92 (range: 0.80–1.00) and an average of 0.56 (range 0.36–0.89) for Pearson’s r between effect sizes across tissues (Fig. 2f). Third, 92%, 74%, 73% and 69% of cis-eQTL in blood, liver, duodenum and muscle, respectively, were replicated in independent datasets (Extended Data Fig. 6f–h). Fourth, effects derived from allele-specific expression (ASE) analysis were correlated with those from cis-eQTL mapping (Fig. 2g and Extended Data Fig. 6i–k). In addition, we conducted an exploratory analysis of trans-eQTL in 12 tissues with over 150 individuals and detected an average of 80 trans-eGenes (false discovery rate, FDR < 0.05) across tissues (Supplementary Fig. 12a,b). We took the muscle that had the largest sample size (n = 1,321) as an example to conduct an internal validation of trans-eQTL by randomly and evenly dividing samples into two groups. We observed that the replication rate (π1) between the two groups was 0.4 and the Pearson’s correlation of effect sizes of significant trans-eQTL between groups was 0.5 (Supplementary Fig. 12c).

To understand how cis-eQTL are shared across pig breeds, we considered muscle as an example. We divided muscle samples into eight breed groups (all referred to as ‘breeds’ hereafter) and performed cis-eQTL mapping separately (Extended Data Fig. 7a and Supplementary Table 13). Across all eight breeds, we detected 9,548 unique cis-eGenes, of which 97.1% could be replicated in at least two of these breeds (Fig. 2h and Extended Data Fig. 7b,c). The replication rates were higher in breeds with more samples (Extended Data Fig. 7d). For instance, the Landrace × Yorkshire cross-breed had the largest sample size (n = 374) replicated on average 95.6% of the cis-eQTL detected in the other seven breeds (Extended Data Fig. 7d). The cis-eQTL effects were positively correlated between breeds and clearly separated from other tissues (Fig. 2i and Extended Data Fig. 7e). In addition, the effects of cis-eQTL from the multibreed meta-analysis were correlated with those from the combined muscle population (Extended Data Fig. 7f). Compared to the single-breed meta-analysis, the combined population detected 86.2% more cis-eQTL (Extended Data Fig. 7g). To explore whether breed interacts with genotype to modulate expression of some genes, we conducted breed-interaction cis-eQTL (bieQTL) mapping. In total, 589 genes had at least one significant bieQTL in 13 tissues (Fig. 2j,k, Extended Data Fig. 7h,i and Supplementary Table 14). Furthermore, we conducted a cell-type deconvolution analysis in seven tissues, demonstrating the variation of cell-type composition across bulk tissue samples (Extended Data Fig. 8a). A total of 376 genes had at least one significant cell-type interaction cis-eQTL (cieQTL) in three tissues (Fig. 2l–m, Extended Data Fig. 8b,c and Supplementary Table 14). In addition, we validated half of bieQTL and cieQTL with the ASE approach (Fig. 2j,l and Extended Data Fig. 8d–g).

Tissue-sharing patterns of molQTL

Tissues with similar functions clustered together, and the tissue relationship was consistent across all ten data types, including the five types of molQTL and the respective molecular phenotypes (Fig. 3a,b and Extended Data Fig. 9a,d). The most easily accessible samples, that is, blood and milk cells, showed an average correlation of 0.51 cis-eQTL effects with other tissues. Both had the highest similarity to immune tissues, followed by intestinal tissues, and finally testis and embryonic tissues. The overall tissue-sharing of molQTL showed a U-shaped curve (Fig. 3c). Among them, cis-eQTL of PCG had the highest degree of tissue-sharing, followed by cis-lncQTL, cis-sQTL, cis-eeQTL and finally cis-enQTL (Fig. 3c and Extended Data Fig. 9e). An eGene tended to be regulated by cis-eQTL of smaller effect if it showed a higher level of tissue-sharing or was expressed in more tissues (Fig. 3d and Extended Data Fig. 9f). The higher the tissue-sharing of eGenes, the larger the minor allele frequency (MAF) of their cis-eQTL, and the closer the distance of their cis-eQTL to TSS (Fig. 3d). In addition, eGenes that were active in more tissues had a decreased PhastCons score (that is, less sequence constraint), while genes that were not eGenes (non-eGenes) in more tissues had an increased PhastCons score (Fig. 3e). The shared non-eGenes in the 34 tissues were substantially enriched in fundamental biological processes (Supplementary Table 15). We summarized four types of SNP–gene pairs and observed that 1.8% (1,166/64,250) of top cis-eQTL of the same eGenes had an opposite effect in at least one tissue pair, representing 3.1% (467/14,988) of all detected eGenes (Fig. 3f). Compared to other tissue pairs, blood and testis showed the highest proportion (25%) of eGenes with opposite cis-eQTL effects (Fig. 3g). For example, ODF2L, which showed the opposite direction of eQTL effect (rs329043485) between blood and testis (Fig. 3h and Extended Data Fig. 9g–h), is involved in negative regulation of cilium assembly and spermatogenesis.

Functional annotation of molQTL

Compared to other molQTL, cis-sQTL had a higher enrichment for missense variants, variants with a high impact on protein sequence and variants in splice region and acceptor sites (Fig. 4a and Supplementary Fig. 13a). Although there was a significant enrichment of molQTL in exonic annotations (for example, synonymous and missense), the proportion of such variants over all the molQTL was around 5.4%, that is, 5.4% for eQTL, 5.5% for sQTL, 5.2% for eeQTL, 5.4% for lncQTL and 5.8% for enQTL. This finding was consistent with human GTEx, and RatGTEx. Looking at chromatin states, these five types of molQTL showed the highest enrichment in active promoters, followed by those proximal to TSS and ATAC islands (Fig. 4b and Supplementary Fig. 13b). The molQTL with higher causality scores showed a higher enrichment in functional features (Supplementary Fig. 13c,d). Among all the five types of molQTL, cis-enQTL with high causality scores had the highest enrichment for enhancer-like chromatin states (Supplementary Fig. 13d). An average of 64% of cis-eQTL could potentially modify transcription factor binding sites (Supplementary Table 16). Although they showed a weak enrichment for molQTL (except for cis-enQTL; Fig. 4b), enhancers had a higher enrichment for cis-eQTL in the matching tissue compared to nonmatching tissues (Fig. 4c). Notably, the top cis-eQTL tended to be enriched in promoters rather than enhancers, whereas the reverse was observed for the second- and third-ranked cis-eQTL (Fig. 4d). In addition, molQTL showed tissue-specific enrichment for hypomethylated regions (HMRs) and allele-specific methylation loci (Supplementary Fig. 13e). In muscle, 2,016 cis-eQTL, 4,694 cis-eeQTL, 524 cis-lncQTL, 5,174 cis-enQTL and 1,590 cis-sQTL were mediated by methylation QTL (Supplementary Fig. 13f,g and Supplementary Table 17). The long-distance cis-eQTL were substantially enriched in the same topologically associating domain (TAD) as TSS of target genes after accounting for the cis-eQTL-TSS distance (Fig. 4e). This suggests that long-range cis-eQTL may affect gene expression by mediating 3D genome interactions. For instance, in muscle, the second independent cis-eQTL of BUD23 was 385 kb upstream of its TSS, and located within the same TAD of the TSS, as well as was surrounded by HMRs and enhancers (Fig. 4f).

Interpreting GWAS loci with molQTL

To study the regulatory mechanisms underlying complex traits in pigs, we examined 268 GWAS summary statistics of 207 complex traits (Supplementary Table 18) and found that GWAS signals were enriched in molQTL (Fig. 5a and Supplementary Fig. 14a–e). Among them, cis-eQTL/cis-sQTL showed the highest enrichment (~1.61-fold, s.e. = 0.014), followed by cis-eeQTL (1.57-fold, s.e. = 0.015), cis-lncQTL (1.55-fold, s.e. = 0.014) and cis-enQTL (1.51-fold, s.e. = 0.017; Fig. 5a and Supplementary Fig. 14f). Averaging across 198 traits, approximately half of the heritability was mediated by PCG expression and alternative splicing, followed by exon expression (46.4%), enhancer expression (29.5%) and lncRNA expression (28.5%; Supplementary Fig. 14g). The amounts of heritability of complex traits explained by molQTL were higher than those explained by MAF-matched random SNPs (Fig. 5b and Supplementary Fig. 14h).

Furthermore, we employed four complementary approaches to detect shared regulatory variants/genes associated with both molecular phenotypes and complex traits, including colocalization via fastENLOC, Mendelian randomization via SMR, single-tissue transcriptome-wide association studies (TWAS) via S-PrediXcan and multi-tissue TWAS via S-MultiXcan. Of 1,507 significant GWAS loci that were tested in the cis-eQTL mapping, 983 (65%) were interpreted with cis-eQTL in at least one tissue (Fig. 5c and Supplementary Table 19). Among them, only 33% were colocalized with the nearest genes of the lead GWAS SNP (Fig. 5d). GWAS loci mapped with higher significance levels were more likely to be colocalized with cis-eQTL (Fig. 5e). The eGenes shared by more tissues tended to be colocalized with more GWAS loci (Fig. 5f). The number of colocalization events of a trait was determined by the statistical power of both GWAS and cis-eQTL mapping (Supplementary Fig. 14i–o).

To prioritize tissues relevant for complex trait variation, we defined a ‘tissue relevance score’ through the number of colocalization events adjusted by sample size and eGene discovery ratio of a tissue (Supplementary Table 20). We only considered 14 tissues with over 100 samples and found that, for instance, the ileum was the most relevant tissue for both average daily gain (ADG) and loin muscle area (Fig. 5g). For instance, ABCD4 was the top associated gene in the small intestine TWAS of the average backfat thickness (BFT; Fig. 5h). It also had a significant association with BFT in the brain. The GWAS loci of BFT were colocalized with cis-eQTL of ABCD4 in both the brain and small intestine. Although these lead SNPs were different in these two tissues, they had a relatively high LD (r2 = 0.71), potentially tagging the same underlying causal variant. The fine-mapped SNP (rs1114012229) of the BFT GWAS was in a high LD (r2 = 0.85) with the fine-mapped SNP (rs1107405934) of the ABCD4 eQTL (Supplementary Fig. 15a). In addition, rs1107405934 was specifically associated with the expression of ABCD4 in both intestinal tissues and the brain (Supplementary Fig. 15b, c).

Furthermore, we employed the same GWAS integrative analysis for other molQTL (Supplementary Tables 21–24). Around 80% (1,204/1,507) of significant GWAS loci could be explained by at least one molQTL in the 34 tissues. Of note, 8.2%, 3.8%, 3.5%, 1.9% and 0.4% of all 1,507 GWAS loci were only explained by cis-eQTL, cis-sQTL, cis-eeQTL, cis-lncQTL and cis-enQTL, respectively (Extended Data Fig. 10a,b). For example, a GWAS signal of ADG on chromosome 13 was only colocalized with cis-eQTL of CFAP298-TCP10L in the colon, but not with its cis-sQTL or cis-eeQTL (Extended Data Fig. 10c). The GWAS signal for BFT on chromosome 15 was exclusively colocalized with cis-sQTL of MYO7B in small intestine, while the GWAS signal of litter weight was exclusively colocalized with cis-eeQTL of FBXL12 in uterus (Extended Data Fig. 10d–e). In addition, 63% of GWAS loci were colocalized with more than one type of molQTL (Extended Data Fig. 10a and Supplementary Fig. 16). In addition, we detected 512 lncRNA-PCG-trait trios with significant pleiotropic associations (Supplementary Table 25 and Extended Data Fig. 10f).

The shared genetic regulation between humans and pigs

By examining GTEx (v8) in humans, we found that one-to-one orthologous genes (n = 15,944) contributed to an average of 82% and 87% of overall expression across 17 common tissues in pigs and humans, respectively (Supplementary Fig. 17a,b). The visualization of variation in gene expression among all 12,453 samples clearly recapitulated tissue types rather than species (Supplementary Fig. 17c–h). The number of tissues in which an eGene was active was correlated between species (Supplementary Fig. 17i). The eGenes in a pig tissue generally had a higher enrichment for eGenes in the matching tissue in humans compared to other tissues (Fig. 6a). Furthermore, we observed a significant correlation (r = 0.56) of averaged eQTL effect between humans and pigs (Fig. 6b), which was higher than that (r = 0.24) observed between humans and rats previously. In general, matching tissues had a higher correlation of eQTL effect compared to nonmatching tissues (Supplementary Fig. 18a,b and Supplementary Table 26). We observed a significant but weak correlation (r = 0.09) of cis-h2 between humans and pigs (Supplementary Fig. 18c), similar to that between humans and rats (r = 0.10). In addition, tissue-specific expression of genes was more similar between pigs and humans than that between cattle and humans (Supplementary Fig. 19a–c). Similarly, the eQTL effects of orthologous genes in pigs were more correlated with those in humans than with those in cattle (Supplementary Fig. 19d–f).

We divided orthologous genes into four groups (that is, ‘neither’, ‘human-specific’, ‘pig-specific’ and ‘shared’) in each of the 17 matching tissues and observed a significant difference in expression levels among them. The shared eGenes had a lower tissue specificity in expression levels and regulatory effects, compared to genes in the other three groups (Fig. 6c and Supplementary Fig. 18d). A total of 783 eGenes were active in all tissues in both species, which were substantially enriched in metabolic processes (Supplementary Table 27). A total of 194 genes were not eGenes in any tissues in both species, and these were substantially enriched in essential biological functions (Supplementary Table 28). Expression levels of genes were negatively correlated with LOEUF scores, which was consistent across the four groups of genes (Supplementary Fig. 18e). Among them, ‘Shared’ eGenes had the weakest negative correlation of expression levels and LOEUF scores, while ‘neither’ eGenes had the strongest negative correlation (Supplementary Fig. 18e). Of specific note, although they had the highest expression levels, ‘Shared’ eGenes showed the strongest tolerance to loss of function mutations among the four gene groups (Fig. 6d). Compared to other genes, eGenes shared in both species had the lowest evolutionary DNA sequence constraints, whereas shared non-eGenes showed the opposite trend (Supplementary Fig. 18f). The expression levels of most genes were weakly or even not correlated with their PhastCons scores, eQTL detection and cis-h2 estimates across tissues (Supplementary Fig. 18g–i).

To investigate whether the regulatory mechanism of complex phenotypes was conserved between humans and pigs, we compared the effect sizes of orthologous genes between 268 pig and 136 human complex phenotypes based on the summary statistics of TWAS (Supplementary Table 29). We observed a clear deviation (Wilcoxon rank-sum test P = 2.16 × 10−62) of the observed P values of TWAS correlations from the permutation-based null distribution (Supplementary Fig. 20a), and a total of 89 pig–human trait pairs were significant (FDR < 0.1; Supplementary Table 30, Fig. 6e and Supplementary Fig. 20b–e). We then chose several well-recognized homologous trait pairs between humans and pigs to perform the meta-TWAS, with several nonhomologous trait pairs as negative controls. For homologous trait pairs, cross-species meta-TWAS improved the discovery of trait-associated genes in humans (Fig. 6f). For instance, cross-species meta-TWAS analysis of pig average BFT and human body weight (BW) revealed eight new genes (FDR < 0.05) associated with BW in humans (Fig. 6g). Based on GWAS of 3,302 traits in humans, phenome-wide association studies (PheWAS) showed that five of these eight genes were associated with other BW-relevant traits, such as height, birth weight and BMI (Supplementary Table 31). Furthermore, gene groups with higher significance in the pig BFT TWAS showed a higher enrichment for heritability of human BW (Fig. 6h).

Discussion

The pilot PigGTEx offers a deep survey of genetic regulatory effects across a wide range of tissues, representing a substantial advance in the understanding of the gene regulation landscape in pigs. This multi-tissue catalog of regulatory variants further advances our understanding of biological mechanisms underlying complex traits of economic importance in pigs. On average, about 80% of GWAS loci tested in pigs are linked to candidate target genes by molQTL in the PigGTEx, comparable with 78% of GWAS loci linked by GTEx in humans. The PigGTEx will eventually enhance genetic improvement programs through the development of advanced biology-driven genomic prediction models that depend on informative SNPs. We also demonstrate the level of similarity between pigs and humans in gene expression, gene regulation and complex trait genetics. This extensive comparison of the pig and human genomes at multiple biological levels will be instructive for deciding which human diseases and complex traits make the pig the most suitable animal model.

Although a fraction of regulatory effects are shared across tissues, we note that some tissues, like the testis and those from early developmental stages, are distinct from other primary tissues. Due to the differences in sample size and other biological factors (for example, breed and cell-type composition) across tissue types in the current phase of PigGTEx, underrepresented tissues at multiple development stages are still required to gain a more comprehensive view of tissue-specific gene regulation and to refine the tissue-trait map in pigs. To elucidate gene regulation at single-cell resolution, we conducted an exploratory analysis to discover cell-type-interaction regulatory effects through an in silico cell-type deconvolution. The cieQTL identified for several cell types indicate that a vast majority of cell-type-specific cis-QTL remain to be detected,. Compared to cis-eQTL, trans-eQTL often have smaller effect sizes and thus require hundreds of thousands of samples to be discovered,. Although integrating multi-omics data provides insight into the molecular mechanisms underlying regulatory variants, experimental follow-ups are necessary to functionally validate and characterize these regulatory variants at large scale,.

Ethics

It is not applicable because no biological samples were collected and no animal handling was performed for this study.

RNA-seq data analysis and molecular phenotype quantification

In total, we gathered 11,323 publicly accessible raw RNA-seq datasets, representing 9,530 distinct samples (downloaded from NCBI SRA by 26 February 2021), of which 98.13% were generated using the Illumina platform. We removed 121 embargoed RNA-seq samples and then processed all the remaining RNA-seq samples using a uniform pipeline. Briefly, we first trimmed adaptors and discarded reads with poor quality using Trimmomatic (v0.39). We then aligned clean reads to the Sscrofa11.1 (v100) pig reference genome using STAR (v2.7.0). We kept 8,262 samples with more than 500K clean reads and uniquely mapping rates ≥ 60% for subsequent analysis (Supplementary Table 1). We extracted the raw read counts of 31,871 Ensembl (Sscrofa11.1 v100) genes by featureCounts (v1.5.2) and obtained their normalized expression (that is, transcripts per million (TPM)) using Stringtie (v2.1.1). We removed 544 samples in which less than 20% of all annotated genes were expressed (TPM ≥ 0.1), resulting in 7,597 samples. We then visualized the variance in gene expression among samples using t-distributed stochastic neighbor embedding (t-SNE). After filtering out outliers within each of the tissues, we eventually kept 7,095 samples for subsequent analysis (Supplementary Table 1). We employed MEGA (vX) to build a neighbor-joining tree of these samples based on TPM and then visualized it by iTOL (v6).

For PCG expression, we considered 21,280 PCGs from the Ensembl annotation (Sscrofa11.1 v100). For exon expression of PCGs, we extracted raw read counts of 290,536 exons by featureCounts (v1.5.2) and normalized them as TPM. To explore enhancer expression, we downloaded the previously predicted enhancers (strong active enhancers, EnhA) from 14 pig tissues. We merged these enhancer regions across tissues using bedtools (v2.30.0), resulting in 158,998 nonredundant enhancer regions. To control the potential contamination of transcribed genes, we only focused on transcribed enhancers that were not overlapped with any known gene regions (including protein-coding gene, lncRNA, pseudogene, tRNA, miRNA and snoRNA)–, resulting in 3,679 enhancers. We obtained raw read counts of these nonredundant enhancer regions from all 7,095 RNA-seq samples by featureCounts (v1.5.2), followed by TPM normalization. For lncRNA expression, we obtained 17,162 lncRNAs predicted from 33 Iso-Seq datasets, representing ten tissues from four animals by using FEELnc. We applied the same approach to extract and normalize lncRNA expression as above.

For alternative splicing, we used Leafcutter (v0.2.9) to quantify excision levels of introns and then to identify splicing events within each tissue as described in the following: (1) converting aligned bam files from STAR (v2.7.0) into junction files using the script bam2junc.sh; (2) generating intron clusters using the script leafcutter_cluster.py, and then mapping them to genes by the map_clusters_to_genes.R script with exon coordinates extracted from the Ensembl annotation file (v100); (3) discarding introns without any read count in more than 50% of samples or with fewer than max(10, 0.1n) unique values, where n is the sample size; (4) filtering out introns with low complexity: ∑i(|zi| < 0.25) ≥ n-3 and ∑i(|zi| > 6) ≤ 3, where zi is the z score of the ith cluster read fraction across individuals; (5) using prepare_phenotype_table.py script to normalize filtered counts and convert them into BED format, where start/end positions correspond to the TSS of corresponding genes. Furthermore, we normalized excision levels of introns as percent spliced-in (PSI) values.

MolQTL mapping

For molQTL mapping within each of the 34 tissues, we only considered SNPs with MAF ≥ 5% and minor allele count ≥ 6, resulting in an average of 2,705,637 SNPs (ranging from 1,815,729 in synovial membrane to 3,004,852 in muscle). We computed genotype PCs based on the filtered SNPs within each of the tissues using SNPRelate (v1.26.0). We used the top five and ten genotype PCs to account for the population structure among samples in tissues with <200 and ≥200 samples, respectively (Extended Data Fig. 2f). To account for technical confounders among RNA-seq samples, we used the probabilistic estimation of expression residual (PEER) method, implemented in PEER (v1.0) R package, to estimate a set of latent covariates within each tissue based on gene expression matrices. We obtained a total of 60 PEER factors in each tissue and assessed their relative contributions (that is, factor weight variance) to gene expression variation using the PEER_getAlpha function. We decided to use the top ten PEER factors for each tissue as covariates when conducting molQTL mapping for PGC, exon, lncRNA and enhancer expression (Extended Data Fig. 2g). For cis-sQTL mapping, we estimated and fitted ten PEER factors from the splicing quantifications of genes within each tissue. To understand whether known covariates can be captured by PEER factors, we fitted a linear regression model to estimate the proportion of variance in known confounders that were explained by the top ten PEER factors.

For cis-eQTL mapping, we first normalized the PCGs expression across samples within each tissue using the trimmed mean of M-value (TMM) method, implemented in edgeR, followed by inverse normal transformation of the TMM. We performed cis-eQTL mapping using a linear regression model, implemented in TensorQTL (v1.0.3), while accounting for the estimated covariates. Within each tissue, we filtered out genes with TPM < 0.1 and/or raw read counts < 6 in more than 80% of samples. We defined the cis-window of PCG as ±1 Mb of TSS and obtained the nominal P values of cis-eQTL with the parameter mode cis_nominal in TensorQTL. We then employed two layers of multiple testing corrections based on the permutation approach, implemented in the TensorQTL. In the first layer, we applied an adaptive permutation approach to calculate the empirical P values of variants within each gene and obtained the permutation P value of the lead variant for each gene. In the second layer, we conducted the Benjamini–Hochberg correction for the permutation P values of lead variants across all tested genes and considered genes with FDR < 5% as the genome-wide significant eGenes and genes without significant cis-eQTL as non-eGenes. To identify significant cis-eQTL associated with eGenes, we defined the empirical P value of the gene that was closest to an FDR of 0.05 as the genome-wide empirical P value threshold (pt). We obtained the gene-level threshold for each gene from the beta distribution by qbeta (pt, beta_shape1, beta_shape2) in R (v4.0.2), where beta_shape1 and beta_shape2 were derived using TensorQTL. We considered SNPs with a nominal P value below the gene-level threshold as significant cis-eQTL for a given gene–tissue pair.

Similarly, we normalized the expression of exons, lncRNAs and enhancers to inverse normal transformed TMM across samples and excluded lowly expressed elements using the same approach as for PCG. We conducted cis-QTL mapping for exons (cis-eeQTL), lncRNAs (cis-lncQTL) and enhancers (cis-enQTL) using TensorQTL. For cis-eeQTL mapping, we defined the cis-window of an exon as the ±1 Mb region of its source gene’s TSS. For exons, lncRNA and enhancer cis-QTL mapping, we defined the cis-window as the ±1 Mb region of the TSS of the source gene, of its TSS and its TSS, respectively. We declared significant cis-QTL for exons, lncRNAs and enhancers using the same approach as done for the cis-eQTL mapping. We defined exons, lncRNAs and enhancers with at least one significant cis-QTL as eExon, eLncRNA and eEnhancer, respectively.

We performed cis-sQTL mapping for genes with splicing quantifications (PSI values) and tested SNPs within ±1 Mb of TSS using TensorQTL (v1.0.3) while accounting for the estimated covariates. To compute the empirical P value of cis-sQTL, we grouped all intron clusters of a gene with the parameter: --phenotype_groups option in the permutation mode of TensorQTL (v1.0.3). We defined sGene and significant cis-sQTL using the same approach as used for cis-eQTL mapping. We refer to the eGene, eExon, eLncRNA and eEnhancer above, as well as sGene collectively as eMolecule.

Conditionally independent molQTL mapping

To identify the multiple independent cis-QTL signals of a given eMolecular, we applied a forward-backward stepwise regression approach, using TensorQTL (v1.0.3) with the parameter: --mode cis_independent. We set the gene-level significance threshold to be the maximum β-adjusted P value for eMolecules within each tissue after correcting for multiple testing as described above. At each iteration, we scanned the new cis-QTL after adjusting for all previously discovered cis-QTL and covariates. In addition, we further employed SuSiE-inf (v1.2) to fine-map the potential causal cis-QTL for each eMolecule.

The tissue-sharing patterns of molQTL

To understand the shared or specific genetic regulatory mechanisms between tissues, we performed a meta-analysis of molQTL across all 34 tissues using MashR (v0.2–6) and METASOFT (v2.0.1) as described above. For MashR (v0.2-6), we only considered the z scores from TensorQTL (v1.0.3; slope/slope_se) of the top cis-molQTL. We obtained the estimated effect sizes (that is, posterior means) and the corresponding significance levels (that is, local false sign rate (LFSR)) from the mash function. We defined a molQTL with LFSR < 0.05 as active in a given tissue. To estimate the pairwise tissue similarity with regard to genetic regulation of gene expression, we calculated the pairwise Spearman’s correlation of effect size estimates of cis-molQTL between any tissue pairs, focusing on SNPs with LFSR < 0.05 in at least one tissue. For METASOFT (v2.0.1), we used summary statistics (that is, slope and slope_se) from TensorQTL (v1.0.3) of molQTL across all tissues. We estimated the meta-analytic effect size using a fixed effect model and calculated M values (posterior probabilities) using the MCMC method. We considered a molQTL with M > 0.7 active in tissue. To evaluate the similarity of tissue-clustering patterns across different data types (that is, PCG expression, splicing quantifications, exon expression, lncRNA expression, enhancer expression, cis-eQTL, cis-sQTL, cis-lncQTL, cis-eeQTL and cis-enQTL), we performed k-means clustering using the k-means function in the stats R package (v4.0.2), in which parameter k was allowed to range from 2 to 20 and the maximum number of iterations was 1,000,000. We calculated the pairwise Rand index to measure the clustering similarity using the rand.index function in the fossil (v0.4.0) R package (v4.0.2).

GWAS summary statistics

To investigate the regulatory mechanisms underpinning complex traits in pigs, we systematically integrated the identified molQTL with summary statistics of 268 meta-GWAS from 207 complex traits of economic importance, representing five trait domains (Supplementary Table 18). In total, we performed 2,056 separate GWAS and conducted the meta-GWAS analysis for the same traits across different populations based on GWAS summary statistics using METAL (v2011-03-25), resulting in 268 meta-GWAS results. To perform the integrative analysis of GWAS and molQTL, we overlapped significant GWAS loci with the 3,087,268 SNPs tested in the molQTL mapping, resulting in 1,507 GWAS loci with lead SNP P < 1 × 10−5.

Enrichment of molQTL and trait-associated variants

To examine whether molQTL was enriched among the significant GWAS variants, we applied three distinct approaches as described in the following. First, we used a simple overlapping approach to examine whether a significant molQTL is more likely to be a significant trait-SNP as described in ref. Briefly, for each tissue, we kept SNPs with the most significant nominal P value for a gene and scaled P values to a comparable level (λ = 10) across 34 tissues. We selected the minimum P value of each SNP in the 34 tissues as the background set, from which we extracted P values for SNPs that overlapped with significant GWAS loci. Second, we applied QTLEnrich (v2) to quantify the enrichment degree between significant molQTL and GWAS loci. We only used summary statistics of 198 GWAS for which ≥80% of SNPs were also tested in the molQTL mapping. Third, we applied the mediated expression score regression method to estimate the heritability of complex trait that was mediated by the cis-genetic component of different molecular phenotypes.

Cis-molQTL-GWAS colocalization

To identify shared genetic variants between the molecular phenotypes and complex traits, we performed a colocalization analysis of molQTL and GWAS loci using fastENLOC (v1.0). Briefly, we obtained the probabilistic annotation of molQTL from the DAP-G (v1.0.0) and then used the summarize_dap2enloc.pl script to generate the annotation file of multi-tissue molQTLs. We generated approximate LD blocks across the entire genome based on the PGRP using PLINK (v1.90). We applied the TORUS tool to generate the posterior inclusion probability of each LD block based on GWAS z scores, followed by the colocalization analysis with fastENLOC (v1.0). We obtained the regional colocalization probability (RCP) of each LD-independent genomic region using a natural Bayesian hierarchical model and considered a gene with RCP > 0.9 as significant. To identify the trait-relevant tissues, we calculated a ‘relevance score’ between a tissue and a trait by dividing the number of colocalized genes by the product of sample size and eGene proportion in this tissue. We only considered 14 tissues with ≥100 samples.

TWAS of complex traits

To explore whether the overall cis-genetic component of a molecular phenotype is associated with complex traits, we conducted single- and multi-tissue TWAS using S-PrediXcan and S-MultiXcan in MetaXcan (v0.6.11), respectively, based on the summary statistics of the meta-GWAS. Briefly, we employed the nested cross-validated elastic net model implemented in S-PrediXcan to predict the five types of molecular phenotypes in all 34 tissues. To train the predictive model, we used the confounder-corrected expression or PSI values as phenotypes and SNPs within the cis-windows of genes as genotypes. We kept only predictive models with cross-validated correlation ρ > 0.1 and prediction performance P < 0.05 for further TWAS analysis. We ran S-PrediXcan on all 268 GWAS to obtain gene–trait associations at a single-tissue level. Based on results from S-PrediXcan, we ran S-MultiXcan to integrate predictions from multiple tissues, yielding the multi-tissue TWAS results. We applied Bonferroni correction and considered a corrected P < 0.05 as significant.

MR analysis between molQTL and GWAS loci

We conducted MR analysis to infer the causality between molecular phenotypes and complex traits using the SMR (v1.03). We first converted the summary statistics of molQTL from TensorQTL (v1.0.3) to BESD format using SMR with the options: --fastqtl-nominal-format --make-besd. We only considered eMolecules with top nominal P value < 1 × 10−5 for the SMR test. We defined gene–trait pairs to pass the SMR test if the Benjamini–Hochberg-adjusted PSMR < 0.05 and PGWAS < 1 × 10−5. For gene–trait pairs that passed the SMR test, we performed the heterogeneity in dependent instruments (HEIDI) test, with PHEIDI ≥ 0.05 reflecting that we could not reject a single causal variant with effects on both molecular phenotype and complex trait. As a cis-regulator, lncRNA can regulate the expression of neighboring PCGs and then can influence complex traits. To understand this etiology of complex traits, we performed an integrative SMR analysis that used three layers of summary-level information from cis-lncQTL, cis-eQTL and GWAS. We used the summary statistics of cis-lncQTL and cis-eQTL as the exposure and the outcome input for SMR (v1.03), respectively, which detected pleiotropic effects between lncRNA and PCG expression. We used Bonferroni correction within each tissue and defined a corrected P < 0.05 as significant.

Comparative analysis between pigs and humans

To explore the genetic similarity of complex traits between pigs and humans, we performed a comparative analysis of TWAS summary statistics. We downloaded public human GWAS summary statistics for 136 complex traits, representing 18 trait domains (Supplementary Table 29). Based on the predictive models in human GTEx v8 (ref. ), we applied the S-PrediXcan to conduct TWAS for all 136 complex traits across 49 human tissues. We only kept TWAS results from 11 major tissues in humans that had matched tissues with ≥100 samples in pigs. We only considered 15,944 one-to-one orthologous genes. For a trait pair, we calculated the Pearson’s correlation of absolute effect size estimated of orthologous genes between pigs and humans within the matching tissue. We applied Benjamini–Hochberg correction for P values of all tested correlations and defined an FDR < 10% as significant. To investigate whether GTEx-like resources can facilitate cross-species gene mapping of complex traits through borrowing ‘information’ at the level of orthologous genes instead of individual variants, we performed a cross-species meta-TWAS analysis through modifying a multi-ancestry meta-TWAS method in humans. We calculated the z statistics of meta-TWAS as follows:, where zTWAS,i and zTWAS,j were the z statistics from pig TWAS and human TWAS results, respectively; ni and nj were the population size of pig TWAS and human TWAS, respectively. If the tested trait is a case–control study, we adjusted the sample size as. We chose several well-recognized homologous trait pairs between humans and pigs to perform the meta-TWAS, and we also selected several nonhomologous trait pairs as negative controls. We divided orthologous genes into ten bins sorted by P values of pig TWAS and estimated the heritability enrichment of different gene bins in homologous trait of humans using LD score regression implemented in LDSC. We performed the PheWAS based on 4,756 GWAS, including 3,302 traits in GWAS ATLAS.

Statistics and reproducibility

No statistical method was used to predetermine the sample size. The details of data exclusions for each specific analysis are available in the Methods section. For all the boxplots, the horizontal lines inside the boxes show the medians. Box bounds show the lower quartile (Q1, the 25th percentile) and the upper quartile (Q3, the 75th percentile). Whiskers are minima (Q1 − 1.5× IQR) and maxima (Q3 + 1.5× IQR), where IQR is the interquartile range (Q3–Q1). Outliers are shown in the boxplots unless otherwise stated. The experiments were not randomized, as all the datasets are publicly available from observational studies. The investigators were not blinded to allocation during experiments and outcome assessment, as the data were not from controlled randomized studies.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Online content

Any methods, additional references, Nature Portfolio reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41588-023-01585-7.

References 95

  1. 1.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  2. 2.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  3. 3.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  4. 4.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  5. 5.
  6. 6.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  7. 7.
  8. 8.
  9. 9.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  10. 10.
  11. 11.
  12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  16. 16.
  17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  18. 18.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  19. 19.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  20. 20.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  23. 23.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  24. 24.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  25. 25.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  27. 27.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  28. 28.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  29. 29.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  30. 30.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  31. 31.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  32. 32.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  33. 33.
  34. 34.
  35. 35.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  36. 36.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  37. 37.
  38. 38.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  39. 39.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  40. 40.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  41. 41.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  42. 42.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  43. 43.
  44. 44.
  45. 45.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  46. 46.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  47. 47.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  48. 48.
  49. 49.
  50. 50.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  51. 51.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  52. 52.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  53. 53.
  54. 54.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  55. 55.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  56. 56.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  57. 57.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  58. 58.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  59. 59.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  60. 60.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  61. 61.
  62. 62.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  63. 63.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  64. 64.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  65. 65.
  66. 66.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  67. 67.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  68. 68.
  69. 69.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  70. 70.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  71. 71.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  72. 72.
  73. 73.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  74. 74.
  75. 75.
  76. 76.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  77. 77.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  78. 78.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  79. 79.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  80. 80.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  81. 81.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  82. 82.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  83. 83.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  84. 84.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  85. 85.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  86. 86.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  87. 87.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  88. 88.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  89. 89.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  90. 90.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  91. 91.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  92. 92.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  93. 93.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  94. 94.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  95. 95.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.